P026: Interim analysis of the efficacy and safety of weekly intravenous tividenofusp alfa in mucopolysaccharidosis type II: A phase 1/2 study
Saved in:
| Main Authors: | Barbara Burton, Joseph Muenzer, Paul Harmatz, Deepa Rajan, Simon Jones, Johanna van den Hout, John Mitchell, Matthew Troyer, Natalie Engmann, Rupa Caprihan, Akhil Bhalla, Imanol Zubizarreta, Arlette Weichert, Peter Chin, Carole Ho |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Genetics in Medicine Open |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2949774425009094 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unmet needs of adults living with mucopolysaccharidosis II: data from the Hunter Outcome Survey
by: Joseph Muenzer, et al.
Published: (2025-07-01) -
Enzyme replacement therapy with galsulfase for mucopolysaccharidosis VI: clinical facts and figures
by: Paul Harmatz
Published: (2010-10-01) -
MUCOPOLYSACCHARIDOSIS TYPE II
by: N.D. Vashakmadze, et al.
Published: (2011-06-01) -
Awareness of Mucopolysaccharidosis in an Otorhinolaryngologic Clinic
by: Hsiang-Yu Lin
Published: (2017-04-01) -
026. Utilizing Pre-Existing Lacerations for Frontal Bone Fracture Management: A Case Report
by: Widya Astuti Muslimin, et al.
Published: (2024-10-01)